Filing Details

Accession Number:
0000950170-24-004656
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-16 16:35:45
Reporting Period:
2024-01-10
Accepted Time:
2024-01-16 16:35:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1680367 Shattuck Labs Inc. STTK Pharmaceutical Preparations (2834) 812575858
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1827204 R Andrew Neill C/O Shattuck Labs, Inc.
500 W. 5Th Street, Suite 1200
Austin TX 78701
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-01-10 56,500 $0.00 200,916 No 4 A Direct
Common Stock Disposition 2024-01-10 2,470 $10.09 198,446 No 4 F Direct
Common Stock Disposition 2024-01-10 25,000 $10.00 173,446 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2024-01-10 113,000 $0.00 113,000 $10.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
113,000 2034-01-10 No 4 A Direct
Footnotes
  1. Consists of 56,500 restricted stock units, which will vest in four equal annual installments beginning on January 10, 2025, subject to the Reporting Person's continued service to the Issuer.
  2. This option represents a right to purchase a total of 113,000 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2025, with the remaining three quarters vesting in equal monthly installments through January 10, 2028, subject to the Reporting Person's continued service to the Issuer.